Pieris Pharmaceuticals to Present at the Oppenheimer 26th Annual Healthcare Conference on December 8th at 3:55 pm EST
BOSTON, MA--(Marketwired - December 01, 2015) - Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a biotechnology company advancing its proprietary Anticalin® bio therapeutic technologies, announced today that its President and CEO, Stephen Yoder, will present …